.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Chinese Patent Office
Baxter
Argus Health
Farmers Insurance
Merck
Novartis
Julphar
Fuji

Generated: September 24, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Fresenius

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
3397III12/6/1978FRESENIUS USA INCFACILITIES AND CONTROLS FOR DELKA, S.A. (SAN SALVADOR, EL SALVADOR CA)
5201III1/3/1984FRESENIUS USA INCMANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES.
5375III5/17/1984FRESENIUS USA INCMANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CANTON, MASSACHUSETTS.
7772IIII11/21/1988FRESENIUS USA INCPACKAGING OF SVP AND LVP PRODUCTS IN OGDEN, UTAH
9014AIV3/13/1991FRESENIUS KABI DEUTSCHLAND GMBHEGG YOLK PHOSPHOLIPID (EYP)
9019III3/15/1991FRESENIUS KABI CLAYTON L PMCT LIPID EMULSION
11240AV12/7/1994FRESENIUS KABI USA LLC V DRUG MASTER FILE 011240, MANUFACTURING FACILITY IN GRAND ISLAND, NY.
11342AV2/13/1995FRESENIUS KABI USA LLC V DRUG MASTER FILE 011342, MANUFACTURING FACILITY IN MELROSE PARK, IL
13134AV8/17/1998FRESENIUS KABI NORGE ASSTERILE MANUFACTURING OPERATIONS IN HALDON, NORWAY
14395III9/8/1999FRESENIUS KABI ONCOLOGY LTDMETAXALONE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Accenture
McKesson
Dow
Teva
Argus Health
Queensland Health
UBS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot